Alnylam Pharma (ALNY) Tops Q4 EPS by 2c
Tweet
Share
E-mail
Get Alerts ALNY Hot Sheet
Price: $291.37 -0.61%
Revenue Growth %: +70.6%
Financial Fact:
Net loss: -90.13M
Today's EPS Names:
CGEH, NAKA, APOG, More
Revenue Growth %: +70.6%
Financial Fact:
Net loss: -90.13M
Today's EPS Names:
CGEH, NAKA, APOG, More
Join SI Premium – FREE
Alnylam Pharma (NASDAQ: ALNY) reported Q4 EPS of ($1.32), $0.02 better than the analyst estimate of ($1.34). Revenue for the quarter came in at $17.5 million versus the consensus estimate of $10.95 million.
For earnings history and earnings-related data on Alnylam Pharma (ALNY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Apogee Enterprises (APOG) Tops Q1 EPS by 16c, Beats on Revenue; Offers FY27 Guidance
- SYNNEX Corp. (SNX) Tops Q2 EPS by 74c, Beats on Revenue; Offers Q3 Guidance
- American Outdoor Brands (AOUT) Tops Q4 EPS by 14c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
